<DOC>
	<DOCNO>NCT02893098</DOCNO>
	<brief_summary>A Multi-Centre , Parallel , Double-Blind , Active comparator , Randomised phase III Clinical Trial</brief_summary>
	<brief_title>A Study Evaluate Safety Efficacy Humia Inj . Patients With Symptomatic Osteoarthritis Knee</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>Primary knee osteoarthritis confirm clinically radiologically accord American College Rheumatology criterion joint pain KellgrenLawrence Grade Ⅰ Ⅲ confirm radiologically within 6 month Knee pain weightbearing pain ( 100mmVAS ) great 40mm Able walk without assistive device Patients willing able provide sign informed consent nature study explain Exclusion criterion : Body Mass Index ( BMI ) &gt; 32 History rheumatoid arthritis inflammatory arthritis knee articular cavity Systemic Intravenous Steroid injection within 1 month , intraarticular corticosteroid injection within 3 month hyaluronate injection within 6 month Has clinically severe tense effusion target knee diagnose Positive accord Patella tap test Undergo Knee Replacement Surgery target knee</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>